首页> 外文期刊>African Journal of Microbiology Research >In vitro antibiotic resistance patterns of Pseudomonas spp. isolated from clinical samples of a hospital in Madinah, Saudi Arabia
【24h】

In vitro antibiotic resistance patterns of Pseudomonas spp. isolated from clinical samples of a hospital in Madinah, Saudi Arabia

机译:假单胞菌的体外抗生素抗性模式。从沙特阿拉伯麦地那一家医院的临床样本中分离

获取原文
获取外文期刊封面目录资料

摘要

Pseudomonas spp. are the leading cause of nosocomial infections. Rise in multidrug resistance among clinical isolates limit therapeutic options and hence increase mortality rate.? Clinical samples (6840) from a hospital in Madinah, Saudi Arabia were collected for a duration of 14 months to study the frequency, antimicrobial sensitivity pattern and seasonal variations of Pseudomonas isolates. Conventional biochemical tests were done to identify the probable organism and antibiotic susceptibility was performed by disc diffusion method and Phoenix automated microbiology 100 ID/AST system. Pseudomonas represented 6.5% of all positive samples of which 65% were from males. Majority of the organisms (85%) were isolated from sputum and wound swabs followed by catheter tips (6.4%) and throat aspirates (3.4%). From the remaining samples, less than 1% organisms were obtained. Assessment of antimicrobial susceptibility to 11 different antibiotics revealed that imipenem was the most effective with highest sensitivity of 99.5%, and low intermediate resistance of only 0.5%. This was followed by ciprofloxacin (97.5%), ceftazidime (96.3%), cefpiramide/amikacin (94.1%), aztreonam (93.2%), gentamycin (87.7%), ampicillin (83%), and cotrimoxazole (80.1%). The most resistant drugs included augmentin (25%), cotrimoxazole (19.9%), ampicillin (17%) and gentamycin (12.3%) while the least resistant were ciprofloxacin (1.5%) and imipenem (0%). Results recommend imipenem as a promising antibiotic against Pseudomonas infections. In case of resistance to imipenem, ciprofloxacin, ceftazidime, cefpiramide, amikacin, and aztreonam may be recommended. In acute cases, Pseudomonas infections may require combined antimicrobial therapy. Frequency of these infections was the lowest (17%) during spring. It was the highest (30%) during summers and winters but reduced to 22% during autumn maybe due to better hygiene during pilgrimage season.
机译:假单胞菌是医院感染的主要原因。临床分离株中多药耐药性的上升限制了治疗选择,因此增加了死亡率。收集了沙特阿拉伯麦地那一家医院的临床样本(6840),历时14个月,以研究假单胞菌分离物的频率,抗菌药敏模式和季节性变化。进行常规生化测试以鉴定可能的生物,并通过盘扩散法和Phoenix自动微生物100 ID / AST系统进行抗生素敏感性分析。假单胞菌占所有阳性样品的6.5%,其中65%来自男性。从痰液和伤口拭子中分离出大多数微生物(85%),然后从导管尖端(6.4%)和喉头抽吸物(3.4%)中分离出来。从剩余的样品中,获得不到1%的生物。对11种不同抗生素的抗菌药敏性评估表明,亚胺培南最有效,最高灵敏度为99.5%,低中间耐药性仅为0.5%。其次是环丙沙星(97.5%),头孢他啶(96.3%),头孢吡胺/阿米卡星(94.1%),氨曲南(93.2%),庆大霉素(87.7%),氨苄青霉素(83%)和科曲唑(80.1%)。耐药性最高的药物包括增强素(25%),考特莫唑(19.9%),氨苄青霉素(17%)和庆大霉素(12.3%),而耐药性最低的药物是环丙沙星(1.5%)和亚胺培南(0%)。结果推荐亚胺培南作为有前景的抗假单胞菌感染的抗生素。如果对亚胺培南耐药,建议使用环丙沙星,头孢他啶,头孢吡胺,阿米卡星和氨曲南。在急性病例中,假单胞菌感染可能需要联合抗菌治疗。在春季,这些感染的频率最低(17%)。在夏季和冬季,它是最高的(30%),但是在秋天,下降到22%,这可能是由于朝圣季节的卫生状况更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号